Home » Health » New Variant of COVID Sparks Global Concern: EG.5 Strain Emerges in Colombia

New Variant of COVID Sparks Global Concern: EG.5 Strain Emerges in Colombia

New variant of the covid has the authorities on alert.

The world is experiencing a new wave of covid, in the United States a considerable increase in hospitalizations is already reported. In Colombia, people who go to hospitals also end up infected with this variant.

Wall Street has seen how companies related to the pharmaceutical industry have been recovering from the fall at the beginning of the year, such is the case of Pfizer.

New variant of the covid has the authorities on alert.

EG.5 variant is in Colombia

Sales of the company’s COVID-19 products bottomed out in the second quarter of 2023 due to the rapid spread of a new Omicron sub-variant called EG.5.

EG.5 is an exceptionally fast spreading variant with numerous mutations in its spike protein relative to previous variants and has already been found in more than 50 countries.

According to the Centers for Disease Control and Prevention, it accounts for 17.3% of new COVID-19 cases as of August 5. At the same time, the number of hospitalizations in the United States for coronavirus continued to grow, reaching 9,056. which is 12.5% ​​more than the previous week.

“This week’s national pool predicts the number of daily COVID-19 hospital admissions to remain stable or trend uncertain, with between 420 and 6,300 daily COVID-19 hospital admissions likely reported on September 4,” the agency said. US CDC.

You are interested: Manuel Elkin Patarroyo announced that he is developing a vaccine against Covid-19.

On August 9, 2023, the World Health Organization classified this strain of coronavirus circulating in the US, the European Union, and China as a “variant of interest.”

At the same time, according to the CDC, the EG.5 variant accounted for around 17.3% of COVID-19 infections, up 5.4% from two weeks ago.

The number of new cases will continue to rise because the updated boosters produced by Pfizer and Moderna were primarily targeted only against the XBB.1.5 subvariant, whose share of the Covid-19 pie continues to decline at a high rate.

2023-08-12 15:06:43
#wave #covid #world #hospitalizations #grow #United #States

Leave a Comment

This site uses Akismet to reduce spam. Learn how your comment data is processed.